This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vergnaud, P. Articles by Delmas, P. D. Search for Related Content PubMed PubMed Citation Articles by Vergnaud, P. Articles by Delmas, P. D.

Undercarboxylated Osteocalcin Measured with a Specific Immunoassay Predicts Hip Fracture in Elderly Women: The EPIDOS Study¹

INSERM U-403, Hôpital E. Herriot (P.V., P.G., P.J.M., P.D.D.), Lyon; and INSERM U-149 (G.B.), Villejuif, France; and Takara Shuzo Co. (K.K.), Shiga, Japan

Address all correspondence and requests for reprints to: Prof. Pierre D. Delmas, INSERM U-403, Hôpital E. Herriot, Pavilon F, 69437 Lyon Cedex 03, France.

Increased levels of circulating undercarboxylated osteocalcin (ucOC), measured indirectly with the hydroxyapatite (HAP) binding assay, have been shown to predict hip fracture risk in a small group of elderly institutionalized women.

The aim of this study was to confirm these findings in a prospective cohort study (EPIDOS prospective study) of 7598 healthy, independently living women over 75 yr of age. One hundred and four women who sustained a hip fracture during a 22-month follow-up period were age matched with 255 controls who did not fracture. Baseline samples were collected before hip fracture for measurement of total OC and ucOC, assessed either with the HAP binding assay or directly with a new enzyme-linked immunosorbent assay (ELISA). This direct ELISA uses human recombinant noncarboxylated OC as a standard and two monoclonal antibodies, one of which was raised against the 14–30 Glu synthetic peptide. We found that the intra- and interassay variations are less than 11%, and this assay exhibits a 5% cross-reactivity with purified human bone OC, used as a source of carboxylated OC. ucOC levels measured with this ELISA correlated well with the HAP binding assay in the population of 359 elderly women (r = 0.82; P < 0.0001).

We estimated the risk of hip fracture for women with levels of ucOC in the highest quartile of values for the 255 controls. We found that increased levels of ucOC measured by ELISA were associated with increased hip fracture risk with an odds ratio (OR) of 1.9 (95% confidence interval, 1.2–3.0), and the ELISA had a greater sensitivity than the HAP assay. In contrast, total OC was not associated with hip fracture risk. After adjustment for femoral neck bone mineral density (BMD) and mobility status assessed by gait speed, ucOC still predicted hip fracture with an OR of 1.8 (1.0–3.0). Women with both femoral neck BMD in the lowest quartile and ucOC in the highest quartile were at higher risk of hip fracture, with an OR of 5.5 (2.7–11.2), than those with only low BMD or high ucOC levels.

In conclusion, we have developed a new specific ELISA for serum ucOC, with low cross-reactivity with carboxylated OC and increased specificity and sensitivity over the HAP assay. Using this new ELISA, we found that ucOC, but not total OC, predicts hip fracture risk independently of femoral neck BMD in elderly women drawn from the general population. Thus, ucOC measurement could be combined with bone mass determination to improve the assessment of hip fracture risk in elderly women.

This article has been cited by other articles:

				I. Kanazawa, T. Yamaguchi, M. Yamauchi, M. Yamamoto, S. Kurioka, S. Yano, and T. Sugimoto Adiponectin Is Associated with Changes in Bone Markers during Glycemic Control in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3031 - 3037. [Abstract] [Full Text] [PDF]

				W. J Craig Health effects of vegan diets Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1627S - 1633S. [Abstract] [Full Text] [PDF]

				P. Garnero New Biochemical Markers of Bone Turnover IBMS BoneKEy, March 1, 2008; 5(3): 84 - 102. [Abstract] [Full Text] [PDF]

				K. D. Cashman Diet, Nutrition, and Bone Health J. Nutr., November 1, 2007; 137(11): 2507S - 2512S. [Abstract] [Full Text] [PDF]

				T Ichikawa, K Horie-Inoue, K Ikeda, B Blumberg, and S Inoue Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells J. Mol. Endocrinol., October 1, 2007; 39(4): 239 - 247. [Abstract] [Full Text] [PDF]

				D. A. Pearson Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants Nutr Clin Pract, October 1, 2007; 22(5): 517 - 544. [Abstract] [Full Text] [PDF]

				T. Sugiyama, T. Takaki, K. Sakanaka, H. Sadamaru, K. Mori, Y. Kato, T. Taguchi, and T. Saito Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli J. Endocrinol., July 1, 2007; 194(1): 213 - 222. [Abstract] [Full Text] [PDF]

				S. Kaptoge, N. Dalzell, E. Folkerd, D. Doody, K.-T. Khaw, T. J. Beck, N. Loveridge, E. B. Mawer, J. L. Berry, M. J. Shearer, et al. Sex Hormone Status May Modulate Rate of Expansion of Proximal Femur Diameter in Older Women alongside Other Skeletal Regulators J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 304 - 313. [Abstract] [Full Text] [PDF]

				T. Ichikawa, K. Horie-Inoue, K. Ikeda, B. Blumberg, and S. Inoue Steroid and Xenobiotic Receptor SXR Mediates Vitamin K2-activated Transcription of Extracellular Matrix-related Genes and Collagen Accumulation in Osteoblastic Cells J. Biol. Chem., June 23, 2006; 281(25): 16927 - 16934. [Abstract] [Full Text] [PDF]

				N. Tsugawa, M. Shiraki, Y. Suhara, M. Kamao, K. Tanaka, and T. Okano Vitamin K status of healthy Japanese women: age-related vitamin K requirement for {gamma}-carboxylation of osteocalcin Am. J. Clinical Nutrition, February 1, 2006; 83(2): 380 - 386. [Abstract] [Full Text] [PDF]

				J. Adams and J. Pepping Vitamin K in the treatment and prevention of osteoporosis and arterial calcification Am. J. Health Syst. Pharm., August 1, 2005; 62(15): 1574 - 1581. [Abstract] [Full Text] [PDF]

				D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies QJM, July 1, 2005; 98(7): 467 - 484. [Abstract] [Full Text] [PDF]

				J. W Nieves Osteoporosis: the role of micronutrients Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1232S - 1239S. [Abstract] [Full Text] [PDF]

				M. Bern Observations on Possible Effects of Daily Vitamin K Replacement, Especially Upon Warfarin Therapy JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 388 - 398. [Abstract] [Full Text] [PDF]

				H. J Kalkwarf, J. C Khoury, J. Bean, and J. G Elliot Vitamin K, bone turnover, and bone mass in girls Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1075 - 1080. [Abstract] [Full Text] [PDF]

				S. L. Booth, K. E. Broe, J. W. Peterson, D. M. Cheng, B. Dawson-Hughes, C. M. Gundberg, L. A. Cupples, P. W. F. Wilson, and D. P. Kiel Associations between Vitamin K Biochemical Measures and Bone Mineral Density in Men and Women J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4904 - 4909. [Abstract] [Full Text] [PDF]

				R. M. Aris, D. A. Ontjes, S. A. Brown, W. Chalermskulrat, I. Neuringer, and G. E. Lester Carboxylated Osteocalcin Levels in Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1129 - 1129. [Full Text] [PDF]

				S. L Booth, K. E Broe, D. R Gagnon, K. L Tucker, M. T Hannan, R. R McLean, B. Dawson-Hughes, P. W. Wilson, L A. Cupples, and D. P Kiel Vitamin K intake and bone mineral density in women and men Am. J. Clinical Nutrition, February 1, 2003; 77(2): 512 - 516. [Abstract] [Full Text] [PDF]

				N. C Binkley, D. C Krueger, T. N Kawahara, J. A Engelke, R. J Chappell, and J. W Suttie A high phylloquinone intake is required to achieve maximal osteocalcin {gamma}-carboxylation Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1055 - 1060. [Abstract] [Full Text] [PDF]

				S. L Booth, A. H Lichtenstein, M. O'Brien-Morse, N. M McKeown, R. J Wood, E. Saltzman, and C. M Gundberg Effects of a hydrogenated form of vitamin K on bone formation and resorption Am. J. Clinical Nutrition, December 1, 2001; 74(6): 783 - 790. [Abstract] [Full Text]

				R. Eastell, D.M. Reid, J. Compston, C. Cooper, I. Fogelman, R.M. Francis, S.M. Hay, D.J. Hosking, D.W. Purdie, S.H. Ralston, et al. Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? QJM, November 1, 2001; 94(11): 575 - 597. [Abstract] [Full Text] [PDF]

				N. C Binkley, D. C Krueger, J. A Engelke, A. L Foley, and J. W Suttie Vitamin K supplementation reduces serum concentrations of under-{gamma}-carboxylated osteocalcin in healthy young and elderly adults Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1523 - 1528. [Abstract] [Full Text] [PDF]

				A. Caillot-Augusseau, L. Vico, M. Heer, D. Voroviev, J.-C. Souberbielle, A. Zitterman, C. Alexandre, and M.-H. Lafage-Proust Space Flight Is Associated with Rapid Decreases of Undercarboxylated Osteocalcin and Increases of Markers of Bone Resorption without Changes in Their Circadian Variation: Observations in Two Cosmonauts Clin. Chem., August 1, 2000; 46(8): 1136 - 1143. [Abstract] [Full Text] [PDF]

				J. Z. Ilich and J. E. Kerstetter Nutrition in Bone Health Revisited: A Story Beyond Calcium J. Am. Coll. Nutr., June 1, 2000; 19(6): 715 - 737. [Abstract] [Full Text] [PDF]

				S. L Booth, K. L Tucker, H. Chen, M. T Hannan, D. R Gagnon, L A. Cupples, P. W. Wilson, J. Ordovas, E. J Schaefer, B. Dawson-Hughes, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1201 - 1208. [Abstract] [Full Text] [PDF]

				S.-M. Kakonen, J. Hellman, M. Karp, P. Laaksonen, K. J. Obrant, H. K. Vaananen, T. Lovgren, and K. Pettersson Development and Evaluation of Three Immunofluorometric Assays That Measure Different Forms of Osteocalcin in Serum Clin. Chem., March 1, 2000; 46(3): 332 - 337. [Abstract] [Full Text] [PDF]

				P. J. Caraballo, J. A. Heit, E. J. Atkinson, M. D. Silverstein, W. M. O'Fallon, M. R. Castro, and L. J. Melton III Long-term Use of Oral Anticoagulants and the Risk of Fracture Arch Intern Med, August 9, 1999; 159(15): 1750 - 1756. [Abstract] [Full Text] [PDF]

				N. B. Watts Clinical Utility of Biochemical Markers of Bone Remodeling Clin. Chem., August 1, 1999; 45(8): 1359 - 1368. [Abstract] [Full Text] [PDF]

				D. Feskanich, P. Weber, W. C Willett, H. Rockett, S. L Booth, and G. A Colditz Vitamin K intake and hip fractures in women: a prospective study Am. J. Clinical Nutrition, January 1, 1999; 69(1): 74 - 79. [Abstract] [Full Text] [PDF]

				C. M. Gundberg, S. D. Nieman, S. Abrams, and H. Rosen Vitamin K Status and Bone Health: An Analysis of Methods for Determination of Undercarboxylated Osteocalcin J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3258 - 3266. [Abstract] [Full Text]

				M. J. Seibel and S. P. Robins Serum Undercarboxylated Osteocalcin and the Risk of Hip Fracture J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 717 - 718. [Full Text] [PDF]